Amgen and Kyowa Kirin to Jointly Develop and Commercialize KHK4083, a Phase 3-Ready, Potential First-In-Class Treatment for Atopic Dermatitis Biotech Investing
FDA Approves LUMAKRAS , The First And Only Targeted Treatment For Patients With KRAS G12C-Mutated Locally Advanced Or Metastatic Non-Small Cell Lung Cancer Biotech Investing
U.S. Food and Drug Administration Approves Bristol Myers Squibb's Zeposia® , an Oral Treatment for Adults with Moderately to Severely Active Ulcerative Colitis1 Biotech Investing
HempFusion CBD and Probulin Probiotics Partner with Two-Time Olympic Gold Medalist and Five-Time World Champion, Kaillie Humphries Biotech Investing
